Jonathan Freve
Director of Finance/CFO chez GALECTO, INC.
Fortune : 9 360 $ au 31/03/2024
Profil
Jonathan P.
Freve is currently the Chief Financial Officer at Galecto, Inc. He previously worked as the Senior Director-Finance at Roche Innovation Center Copenhagen A in 2014, Controller at Virtusa Corp.
from 2007 to 2011, Controller at Brookfield Renewable Partners LP from 2011 to 2014, and Chief Financial Officer & Treasurer at F-Star Therapeutics, Inc. (United States) from 2014 to 2020.
He also worked as a Technical Assistant at PricewaterhouseCoopers LLP.
Mr. Freve received his undergraduate degree from the University of Massachusetts.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GALECTO, INC.
0,04% | 03/01/2024 | 12 000 ( 0,04% ) | 9 360 $ | 31/03/2024 |
Postes actifs de Jonathan Freve
| Sociétés | Poste | Début |
|---|---|---|
| GALECTO, INC. | Director of Finance/CFO | 01/04/2020 |
Anciens postes connus de Jonathan Freve
| Sociétés | Poste | Fin |
|---|---|---|
| SPRING BANK PHARMACEUTICALS, INC. | Director of Finance/CFO | 24/04/2020 |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Director of Finance/CFO | 01/11/2014 |
| BROOKFIELD RENEWABLE PARTNERS L.P. | Comptroller/Controller/Auditor | 01/03/2014 |
| VIRTUSA CORPORATION | Comptroller/Controller/Auditor | 01/04/2011 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | - |
Formation de Jonathan Freve
| University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BROOKFIELD RENEWABLE PARTNERS L.P. | Utilities |
| GALECTO, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA. | Health Technology |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Health Technology |
Virtusa Corp.
 Virtusa Corp. Information Technology ServicesTechnology Services Virtusa Corp. engages in the provision of information technology consulting, technology implementation, and application outsourcing services. Its services include business process management, application services, infrastructure management, enterprise information management, independent validation services, platforming, mobility, enterprise resource planning, business consulting, customer experience management, and cloud transformation. The company was founded by Krishan A. Canekeratne, Tushara Canekeratne and John Gillis in November 1996 and is headquartered in Westborough, MA. | Technology Services |
